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The primary goal of the human microbiome initiative has been to increase our understanding of the structure
and function of our indigenous microbiota and their effects on human health and predisposition to disease.
Because of its clinical importance and accessibility for in vivo study, the oral biofilm is one of the best-
understood microbial communities associated with the human body. Studies have shown that there is a
succession of select microbial interactions that directs the maturation of a defined community structure,
generating the formation of dental plaque. Although the initiating factors that lead to disease development
are not clearly defined, in many individuals there is a fundamental shift from a health-associated biofilm
community to one that is pathogenic in nature and a central player in the pathogenic potential of this
community is the presence of Porphyromonas gingivalis. This anaerobic bacterium is a natural member of the
oral microbiome, yet it can become highly destructive (termed pathobiont) and proliferate to high cell
numbers in periodontal lesions, which is attributed to its arsenal of specialized virulence factors. Hence,
this organism is regarded as a primary etiologic agent of periodontal disease progression. In this review,
we summarize some of the latest information regarding what is known about its role in periodontitis,
including pathogenic potential as well as ecological and nutritional parameters that may shift this commensal
to a virulent state. We also discuss parallels between the development of pathogenic biofilms and the human
cellular communities that lead to cancer, specifically we frame our viewpoint in the context of ‘wounds that
fail to heal’.
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D
espite great advances in our knowledge regard-
ing the causes and risk factors associated with
periodontal diseases, there are no signs of
a decline in its prevalence. In fact, longer retention of
teeth, coupled with an aging population, may give rise
to a future increase in the number of people affected.
Research is just now discovering that changes in the
microbiota of the oral cavity are indicators of systemic
diseases, such as diabetes and cardiovascular disease [see
review (1)]. Moreover, there are data indicating that
chronic inflammation in the oral cavity can exacerbate
these diseases. Hence, although we typically think of
diseases of the oral cavity as non-life-threatening, one
can argue that we are being short sighted; the oral cavity
is indeed connected to the rest of body and oral health is
tightly linked to systemic health.
Historically, the etiology of periodontal disease has
evaded consistent classification. At the turn of the
20th century, the prevailing idea was that bacteria were
non-specific agents acting only second to poor patient
hygiene (2). During the four decades to follow, investiga-
tors hypothesized that plaque from patient to patient
was composed of similar microorganisms and therefore
could not be of a sole etiological agent. It was not until
late 1970s that differences in microbial composition
between healthy and periodontitis-afflicted subjects were
established, indicating that the development of period-
ontal diseases and the changes in microbial community
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composition in the subgingival periodontal pocket are
highly intertwined [reviewed in (3)]. It is now well-
accepted that this disease progression is elicited by
bacteria and results from a fundamental disturbance
in microbial interactions and thereby the interplay of
this complex microbial community with its host.
With hundreds of bacterial species persisting in the
oral cavity, the potential for interactions within the
oral biofilm is innumerable (4, 5). Periodontitis etiology
only makes sense when viewed in light of this complex
community and is best thought of as an inflammatory
disease caused by development of a pathogenic commu-
nity that grows together, evolves together, and becomes
destructive together. Such a pathogenic community is
more than just the sum of its members and persists
because of its diversity (6). It is clear that complex
bacterial communities co-exist in healthy individuals;
yet the environmental, evolutionary, or host-associated
triggers that force the community to become pathogenic
are not fully understood. The primary microbial factor
contributing to periodontal disease progression is a shift
from a benign commensal biofilm to a community with
higher levels of virulent bacteria, and the primary
immunological factor is the destructive host inflamma-
tory response (7). However, the contribution of bacteria
to disease progression remains poorly understood as it
involves such a complex interplay between the host’s
immune system and the resident microbiota (8). Another
complicating factor is that the clinical manifestations of
periodontitis is highly variable and current definitions of
periodontitis are not sufficient to describe such variation
(9, 10). What can be agreed upon is that there is a
fundamental shift of the microbial community that is
correlated to progressive disease intensity.
Porphyromonas gingivalis virulence factors and
its potential for causing dysbiosis
The consortium of bacteria within the oral cavity of
healthy and diseased hosts has been well-characterized
(see reviews 4, 21). In general, the assemblage in the
supragingival plaque in healthy adults is composed
primarily of Gram-positive species belonging to the
genera of Actinomyces and Streptococcus, and to the
Gram-negative genus Veillonella (11, 12), and patients
with periodontal disease have a greater proportion of
Gram-negative, proteolytic, bacteria such as P. gingivalis
or Tanneralla forsythia, as well as species of Prevotella,
Fusobacterium, and Treponema in their subgingival
plaque (3, 1116). Supragingival plaque has been
implicated as a host environment for persistence of the
Gram-negative bacteria, as low levels of these organisms
are found in healthy adults (11, 15, 1719). While these
survey studies have been instrumental in the identifica-
tion of key anaerobes contributing to the progression of
disease, the question of what are the triggers that induce
a change from oral health to disease remains unex-
plained. In fact, recent studies have actually challenged
the paradigm that patients with periodontitis are
primarily colonized by Gram-negative species (2023).
P. gingivalis is best described as a pathobiont, i.e. a
natural member of the human microbiota that under
certain perturbations to the host and/or microflora
can cause pathology (2023). While it is thought that
most people harbor P. gingivalis at some level in
the mouth, a shift in the microbial composition is
associated with its out-growth and development of period-
ontitis (Fig. 1) (2428). P. gingivalis is known to be highly
proteolytic, with primary activity from a class of endo-
peptidases known as gingipains that are critical virulence
factors important for nutrient acquisition, located on the
cell surface, in the outer membrane, and importantly
extracellularly and non-cell associated (2936). Proteoly-
sis actively changes the environmental conditions; im-
portantly, causing a pH increase, thus creating an
environment more hospitable to many Gram-negative
anaerobes. As cell numbers increase, the biofilm at the
core becomes anoxic and nutrients are a commodity,
which in turn makes the action of the proteases even more
important. These proteases have also been shown to
impact the host, both by the tissue destruction that
facilitates nutrient liberation and on the immune system
by the break-down of the cytokine response (37, 38).
Complexed with lipopolysaccharides (LPS) and adhesins,
gingipains have been shown to temper host immunity
concurrent with host tissue destruction (39).
It was recently proposed that P. gingivalis is a
keystone microorganism, such that within a healthy
microflora it can cause dysbiosis and later disease (40).
It was also recently shown that P. gingivalis, at very low
colonization levels, can be sufficient to modify the oral
commensal microbial community composition leading
to inflammatory periodontal bone loss, however on its
own, it cannot induce disease in germ free mice (41).
In contrast, several studies have demonstrated that
P. gingivalis can be present in the subgingival biofilm
and colonize the epithelium in the absence of period-
ontal disease in an otherwise healthy mouth (4245).
These data indicate that the pathogenic potential of P.
gingivalis is not solely dependent on its ability to
colonize and proliferate; its pathogenicity is clearly
related to both its physiological state and its association
with the microbial consortium.
Interestingly, P. gingivalis presence is also associated
with a shift to a microbial community consisting of
more anaerobic bacteria and an overall increase in
microbial load (46). Along the same lines, a recent
metatranscriptome analysis showed that P. gingivalis
introduced into a healthy polymicrobial model biofilm
community increases the transcription of protein-coding
genes for growth and cell-division (47). Furthermore,
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the addition of P. gingivalis caused the model microbial
community to upregulate genes involved in nitrogen
metabolism. This is not surprising as P. gingivalis is
known for its proteolytic capacity to liberate amino
acids from proteins, which can, in turn, be used by other
microbial community members as well as itself (2936).
Interestingly, organisms associated with oral health such
as Streptococcus gordonii are potential entry points for
P. gingivalis to the biofilm and Fusobacterium nucleatum
biofilms are enhanced with the addition of P. gingivalis
(48, 49). Furthermore, these three organisms are found
to up or down regulate a number of metabolic pathways
upon contact with each other, indicating that they are
actively responding to the presence of each other in the
biofilm (50, 51). Findings from these studies suggest
that bacterial cellcell interactions with P. gingivalis may
be a key to either maintaining health or progression
to disease. These studies suggest that interactions with
P. gingivalis may be key to the progression of period-
ontal disease, and that P. gingivalis plays a crucial role
in causing dysbiosis within the oral microbial commu-
nity, perhaps by serving as a communication disrupter
between the polymicrobial biofilm and the host immune
system; however, given the complexity of the interaction
of the oral biofilm with the host, the precise role of P.
gingivalis in development and/or progression of period-
ontal disease remains unclear.
Importance of iron acquisition mechanisms for
P. gingivalis persistence
Within the oral cavity nutrient availability is in constant
flux, and like any well-developed pathogen P. gingivalis
has devised mechanisms to resist this change. As ob-
served with chemostat studies, P. gingivalis is able
to control the expression of several virulence factors
to survive in nutrient limiting environments (52). The
acquisition of iron, for both humans and microbes,
is a major signal to alter gene expression and protein
production; in bacteria iron acquisition mechanisms
are specifically associated with modulating expression of
virulence determinants (53). When iron is limited, drastic
changes in salivary bacterial profile result, such that
there is an increase in Streptococcus, Gemella spp., and
Granulicatella spp., which can, in turn, alter the landscape
of the oral biofilm. If P. gingivalis is a resident within this
community, it will then, in turn, alter its gene expression
in response to the proliferation of Gram-positives (54).
Furthermore, it has been shown that when P. gingivalis is
grown in a biofilm with T. forsythia, there are distinct
changes in the proteome, particularly for processes
related to iron acquisition (55). Exhaustive research
continues to be conducted on P. gingivalis strategies
and molecular mechanisms for iron acquisition (56, 57).
Hemin, or iron protoporphyrin IX, is the main form













Fig. 1. P. gingivalis-mediated periodontitis is a biofilm associated disease of slow progression. Early within the oral cavity there
is a mixed community of bacteria with an abundance of Gram-positive organisms (purple cocci). Over time (represented by the
triangle at bottom), there is a maturation of the biofilm. External and internal pressures such as an anoxic environment,
mammalian cell infiltrate, viral and phage activity, DNA exchange, nutrient availability, and physical and chemical interactions
of the microbes, drive development. A currently unidentified event occurs that allows for the out-growth of Gram-negative
organisms (red and green rods), in particular P. gingivalis (shown in green). There is also active recruitment of cells of the
immune system, such as neutrophils (shown in purple) to the site, which then brings in a battery of host-derived signaling
molecules, impacting the microbial community.
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hemoglobin through the enzymatic activity of the Arg-
and Lys-gingipains. Lactoferrin is a host-derived iron-
binding glycoprotein, found in salivary and gingival
crevicular fluid that is able to chelate iron and plays an
important role in innate immunity. Studies have shown
that lactoferrin is able to inhibit bacterial adhesion to
surfaces by discouraging the formation of biofilms in
Streptococcus mutans (58). Additionally, lactoferrin dis-
plays proteinase-inhibiting activity against P. gingivalis
Arg- and Lys-specific proteinases and is able to efficiently
disrupt P. gingivalis biofilms (59).
Effect of host-nutrition on oral microbiota
There are numerous factors that affect the health of
the host immune system such as nutrition, lifestyle,
and genetics, and interestingly these factors also impact
periodontal health. Host-nutrition is especially important
to consider when assessing diseases associated with the
oral microbial community; bacteria inhabiting the oral
cavity must adapt to the ever-changing nutrient avail-
ability. A neolithic diet and hygiene showed an intra-
individual shift of bacterial composition of F. nucleatum,
A. naeslundii, Veillonella spp., and Streptococcus spp.,
suggesting that diet free of refined sugars plays an
important role in the composition of microbial micro-
flora (60). A cross-sectional study found that calcium
from milk, total dairy calcium, and fermented foods
were inversely associated with periodontal disease after
adjustment for population, hygiene, and other nutritional
factors (61). Furthermore, the effect of dietary antiox-
idants on periodontal disease may play an important
role in prevention of periodontal diseases, most likely
acting by strengthening the immune system (62). Green
tea-derived polyphenols, catechins, are able to inhibit
the production of chemokine ligands associated with
virulence in P. gingivalis (63, 64). Additionally, an epi-
demiological study of 940 Japanese men showed
an inverse relationship between green tea uptake and
periodontal disease (65). Polyphenols derived from
cranberries show an effect on adherence and biofilm
formation of P. gingivalis and F. nucleatum (66, 67).
Resveratrol, a polyphenol found in wine, increased the
viability of human periodontal ligament cells, decreased
nitric oxide expression, and decreased pro-inflammatory
cytokine production in human periodontal ligament
cells induced by P. gingivalis (68). The antibacterial
properties of blackberry extract show a reduction of
metabolic activity in P. gingivalis, F. nucleatum, and S.
mutans (69). Thus, certain nutrients modulate the human
immune system and alter the oral biofilm formed by P.
gingivalis improving periodontal health. Molecules active
in these extracts might be exploited for development
of therapeutic agents.
Role of bacteriophage and CRISPR regions on
microbial community structure
Over the last few decades, the belief that bacteriophages
(bacterial viruses) are key to maintaining homeostasis in
microbial populations has been developing (7072).
Growing evidence suggests that viruses play a signifi-
cant role in bacterial population control as well as in
the transfer of DNA in oral biofilms (7376). A large
proportion of viruses recovered from the oral cavity
belonged to the order of bacteriophages and contain
integrases, likely indicative of viral DNA integration into
bacterial genomes and replication with the bacterial
host (75). Furthermore, it has been observed that viral
DNA contains genes homologous to genes involved in
bacterial pathogenesis, suggesting that viruses may serve
as vehicles for transfer of pathogenic gene function
among closely related bacteria (7577). Hence, exchange
of viral DNA as a mechanism of horizontal gene trans-
fer within the oral cavity is potentially a key area of
investigation (76). Within the biofilm there is an abun-
dance of DNA either through active bacterial secretion,
contributing to biofilm matrix structure, or passive self-
induced or viral-induced cell lysis, thus the opportunity
for free DNA uptake is likely occurring. In addition,
the physical restraints and close proximity of bacteria
in a biofilm facilitate the intra- and inter-species transfer
of DNA (76). P. gingivalis is thought to have a plastic
genome, and there is a great deal of strain-to-strain
genome variability (7880). A recent report suggested
that most horizontal gene transfer in P. gingivalis occurs
with free DNA uptake with viruses not playing a major
role. However, given the latest research on viruses in the
oral cavity, this will likely be challenged (81). As of yet,
no bacteriophage has been identified for P. gingivalis,
but the natural cell-lysis observed in culture remains to be
classified as either autolysis or phage-mediated. At this
point, what remains unknown is how viruses in the
oral cavity contribute to the development of periodontal
disease, as a number are known vectors of disease (82).
It has been noted in other disease models that viral
communities play a key role in disease development;
specifically, the viral communities, as well as the bacterial,
in the respiratory tract of cystic fibrosis patients differs
greatly from those of healthy individuals (8385). There is
an unmet need to understand the dynamics between
viruses and bacteria in the human oral cavity because
viruses likely help to shape the structure of the human
oral microbiome.
The characterization of the Clustered Regularly Inter-
spaces Short Palindromic Repeat (CRISPR) regions of
bacterial genomes has begun to provide insight into
interactions between viruses and bacteria. Found in most
bacteria and archaea, CRISPR loci, together with Cas
proteins, are a bacterial defense mechanism against
viruses and conjugative plasmids (86). CRISPR systems
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vary greatly among microbial species and repeat
sequences as well as cas genes are very divergent
from bacterium to bacterium in terms of sequence, but
also in terms of spacer sizes and the number of repeats
(87). The Human Microbiome Project (HMP) has
enabled exploration of the diversity and distribution of
CRISPRs in human-associated microbial communities.
CRISPRs were detected in all human sites, and it was
observed that CRISPR spacers are actively acquired in
both gut and mouth (88, 89).
The evolution and occurrence of diverse CRISPRs
have been an active area of research in human oral
microbiome studies. CRISPRs have been identified
that are unique to the oral cavity and have been so
far observed in P. gingivalis, as well as in streptococcal
spp., Aggregatibacter actinomycetemcomitans, Filifactor
alocis, and oral spirochetes (74, 80, 8992). Interestingly,
although not surprising due to the known extensive
genome rearrangements, the two sequenced P. gingivalis
strains have very different CRISPR systems (80). The
complicating factor related to the study of CRISPRs
within the oral microbiome is that, although samples
over time from the same individual and oral site share
the most spacers, spacers from different individuals are
not common (75, 77, 91). Hence, the evolution of
CRISPRs appears to be shaped by subtle environmental
changes and the life histories of bacterial populations.
Essentially, CRISPRs can be thought of as a bacterial
immune system to counteract oral viruses as well as a
way to sustain the bacterial population. The presence
of these gene loci in P. gingivalis provides researchers
with a number of tools for population studies, specifically
CRISPR information can be used to track populations
over time, to infer the ecology and evolution of P.
gingivalis within a periodontal pocket, and to examine
how this contributes to the disease progression or as a
reference to discover biomarkers for disease.
Parallels between periodontal biofilms and the
cellular communities that lead to cancer
Microbial biofilms coexisting with their human hosts
are dynamic cellular communities that mimic tissues
that evolve over one’s lifetime (9395). In cases leading
to disease, this evolution reflects shifts in the bacterial
population composition that result in increased pathogen-
esis, e.g. antibiotic resistance, alteration of host immunity,
etc. Similar changes are seen with the development of
cancer, another progressive, age-dependent disease that
reflects an evolving community of cells that essentially
becomes a tissue ‘ignored’ by host immunity. In addition
to transformed cells, tumors include normal cells, par-
enchyma, stroma, and immune cells, whose presence
are essential for cancer development. Thus, both period-
ontal disease and cancer reflect age-dependent changes
in the composition and function of persistent cellular
communities that evolve to a point of pathogenic cap-
ability that no individual member would demonstrate
alone. Like cancer, periodontal biofilm development
needs to be dissected in its earliest stages, particularly
prior to the rampant pathogenic stage, to determine what
establishes the conditions required for the emergence of
disease. In the following paragraphs, we discuss parallels
between periodontal biofilms and the cellular commu-
nities that lead to cancer; perhaps current knowledge of
cancer development can inform periodontal disease and
vice-versa.
Early study of the immune system clearly showed
that it has evolved to fight acute infections. However,
there is growing appreciation for the ability of the
immune system to ‘tolerate’ disease and establish home-
ostasis (96). Furthermore, there is now evidence for the
immune system actually contributing to the evolution of
chronic diseases, most notably cancer. In the immunoe-
diting hypothesis, the immune system has actually been
proposed to ‘groom’ or ‘educate’ the tumor, eliminating
the cells that are the most readily detected, putting
selective pressure on the tumor to evolve cellular variants
that resist recognition (97). This takes time, in fact in
most cases a lifetime. In a similar fashion one could
envision how an oral biofilm could be ‘trained’ by the
immune system over many years. Particular microenvir-
onments or niches reflect experimental subcommunities
tested for their ability to persist; the quality of the
immune response could differ within/among these
microenvironments. Eventually a tipping point would
be reached where the microbial community, collectively,
has acquired the characteristics necessary to subvert
immunity, such as LPS variation or complement resis-
tance, therefore affording conditions for the emergence
of P. gingivalis and full-blown disease.
Tumors have been described as ‘wounds that fail
to heal’ reflecting a switch from a pro-inflammatory
response to a ‘smoldering’ inflammation or housekeeping
process that actively suppresses anti-tumor immunity
(98, 99). In parallel, a hallmark of periodontitis is that
the disease progresses in periodic ‘bursts’ of tissue de-
struction followed by periods of quiescence where partial
healing will occur; hence there is a pro-inflammatory,
wounding event that is essential for staging the sub-
sequent pathology. A switch from a pro-inflammatory
response to an anti-inflammatory, healing scenario has
also been reported for juvenile periodontal disease (100).
High, pro-inflammatory cytokine production plummets
in the ‘health’ to ‘pre-bone loss’ period in these patients.
The healing phase includes significant collagen deposi-
tion followed by a shift in the microflora. Subsequent
collagen destruction precedes the bone degradation and
loss characteristic of periodontal disease. Gingivitis,
which classically precedes adult periodontal disease,
provides a pro-inflammatory, wounding event essential
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for staging the subsequent pathology mediated by P.
gingivalis (101). The collagen deposited following recov-
ery from gingivitis affords a prime substrate for the
collagenase and Arg- and Lys-specific gingipains pro-
duced by this oral pathogen. It is significant to note that
in addition to mediating significant tissue destruction,
these proteases also temper host immunity by impeding
reactive oxygen species (ROS) production and blocking
the clearance of apoptotic neutrophils, a classic anti-
inflammatory mechanism (102104).
As the core of an evolving tumor becomes hypoxic,
angiogenesis and immune suppression follow with the
catabolism of critical, limiting amino acids (Arg, Trp)
fostering immune suppression (98, 105107). Likewise,
oxidative stress with significant ROS generation and
amino acid depletion are noted with periodontal biofilms
(108110). Furthermore, immune ‘paralysis’, reflecting
antagonistic cytokine signaling, is possible as the biofilm
composition changes with aging (8, 111). Two key com-
ponents of the periodontal biofilm community afford a
classic example of Th1-Th2 cytokine antagonism: HagB
of P. gingivalis triggering TLR4 (Th1 response) and BspA
of T. forsythia ligating TLR2 (Th2 response) (112, 113).
Individually these responses would polarize an immune
response towards a particular T cell subset; concurrently,
they could promote immune paralysis.
Although the mechanisms are clearly distinct, a hall-
mark of both tumors and microbial biofilms is persis-
tence in spite of therapeutic treatments; the latter have
actually been proposed to serve as models for studying
the dynamics and evolution of drug resistant cells
within malignant tissues (114). There also is the physical
challenge of getting drugs to penetrate to the core of
tumors and biofilms. Particularly in response to hypoxia,
cells in both biofilms and tumors deploy efflux pumps
that reduce the efficacy of the drugs that penetrate to
the core of these structures (115119). Biofilms and
tumors also can harbor ‘persister’ or stem cells that
are metabolically dormant and thus resist drug treatment
(120, 121). The successful eradication of tumors or
pathogenic biofilms is particularly difficult due to the
fact that the debulking or debriding of these cellular
communities usually leaves residual cells that can re-
establish disease (122124). Collectively, these challenges
highlight the need to develop therapeutic strategies to
break the immune tolerance that these cellular commu-
nities have established. We must appreciate that the
immune system held the tumor or biofilm in ‘check’
for many years. A return to that scenario is a rational
therapeutic objective. The recent success of novel im-
munomodulatory drugs for certain cancers is validating
this concept and should prove particularly effective
when combined with existing treatment protocols (125
127). Perhaps these advances in oncology, and those
surely to follow, can inform future therapeutic strategies
for both the prevention and the treatment of periodontal
disease.
Concluding remarks
When grown in the laboratory, P. gingivalis produces
a number of virulence determinants that clearly define
this organism as pathogenic, yet the underlying factors
that result in the in vivo switch this organism makes
from ‘biont’ to ‘pathos’ is not clear. On its own, P.
gingivalis does not induce disease in germ free mice,
yet it can transform a benign microbial community to
a pathogenic one leading to inflammatory periodontal
bone loss. On the other hand, P. gingivalis has been
found to colonize the gingival epithelium in the absence
of periodontal disease in an otherwise healthy mouth.
Hence, the pathogenic potential of P. gingivalis is
not solely linked to its ability to grow; its role in the
development of a pathogenic biofilm appears to be
dependent on both its physiological state and intercel-
lular interactions within the microbial consortium.
Throughout this review we have highlighted the inter-
connectedness of microbes within the oral biofilm
community, where different genera will actively respond
to the presence or absence of one another. Also, in order
to emphasize the dynamic and complex nature of the
oral biofilm, we have presented parallels between human
cellular communities that lead to cancer and develop-
ment of pathogenic biofilms. We also remarked on
how the population of P. gingivalis likely evolves
within the periodontal pocket over a life time. To
unravel such a complex biological system, requires
a greater understanding of the microbial players within
the community, so investment in the development of
new model organisms is warranted. Moreover, given
the strong foundation of knowledge regarding the oral
microbiome, research in this area will likely lead to some
remarkable discoveries regarding the collective behavior
of these uni-cellular organisms.
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